LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.49 | 770.25 | 3438 | 7555 | 0.4550 | 0.5748 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.71 | 770.25 | 2746 | 8001 | 0.3432 | 0.4571 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.71 | 770.25 | 3642 | 8001 | 0.4552 | 0.5842 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.94 | 770.25 | 2843 | 8444 | 0.3367 | 0.4594 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.94 | 770.25 | 3755 | 8444 | 0.4447 | 0.5818 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 61.16 | 770.25 | 3014 | 8892 | 0.3390 | 0.4720 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 61.16 | 770.25 | 3965 | 8892 | 0.4459 | 0.5909 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.39 | 770.25 | 3148 | 9326 | 0.3376 | 0.4789 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.39 | 770.25 | 4110 | 9326 | 0.4407 | 0.5927 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.61 | 770.25 | 3336 | 9736 | 0.3427 | 0.4926 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.61 | 770.25 | 4302 | 9736 | 0.4419 | 0.6000 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.83 | 770.25 | 3496 | 10078 | 0.3469 | 0.5034 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.83 | 770.25 | 4435 | 10078 | 0.4401 | 0.6030 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.05 | 770.25 | 3652 | 10413 | 0.3507 | 0.5132 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.05 | 770.25 | 4600 | 10413 | 0.4417 | 0.6091 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.27 | 770.25 | 3766 | 10730 | 0.3510 | 0.5183 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.27 | 770.25 | 4769 | 10730 | 0.4444 | 0.6157 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.50 | 770.25 | 3953 | 10991 | 0.3596 | 0.5319 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.50 | 770.25 | 4905 | 10991 | 0.4463 | 0.6205 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.75 | 770.25 | 4083 | 11262 | 0.3625 | 0.5387 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.75 | 770.25 | 5058 | 11262 | 0.4491 | 0.6263 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.98 | 770.25 | 4273 | 11518 | 0.3710 | 0.5512 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.98 | 770.25 | 5160 | 11518 | 0.4480 | 0.6281 | MN20160304_L02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 81.20 | 770.25 | 4429 | 11766 | 0.3764 | 0.5601 | MN20160304_L02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 81.20 | 770.25 | 5304 | 11766 | 0.4508 | 0.6332 | MN20160304_L02 | L16 |